Anna Laukner - Search Results

Year	Number of Results
2008	1
2009	4
2010	3
2011	1
2012	1
2013	3
2014	2
2015	3
2016	2
2017	3
2018	1
2020	1
2024	0

1

van den Wijngaard CC, Hofhuis A, Wong A, Harms MG, de Wit GA, Lugnér AK, Suijkerbuijk AWM, Mangen MJ, van Pelt W. van den Wijngaard CC, et al. Among authors: lugner ak. Eur J Public Health. 2017 Jun 1;27(3):538-547. doi: 10.1093/eurpub/ckw269. Eur J Public Health. 2017. PMID: 28444236

2

Mitigation of pandemic influenza: review of cost-effectiveness studies.

Lugnér AK, Postma MJ. Lugnér AK, et al. Expert Rev Pharmacoecon Outcomes Res. 2009 Dec;9(6):547-58. doi: 10.1586/erp.09.56. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19941432 Review.

3

An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health.

Lugnér AK, Krabbe PFM. Lugnér AK, et al. Expert Rev Pharmacoecon Outcomes Res. 2020 Aug;20(4):331-342. doi: 10.1080/14737167.2020.1779062. Epub 2020 Jun 17. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 32552002 Review.

4

The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases.

Suijkerbuijk AW, Donken R, Lugnér AK, de Wit GA, Meijer CJ, de Melker HE, Bogaards JA. Suijkerbuijk AW, et al. Among authors: lugner ak. Expert Rev Vaccines. 2017 Apr;16(4):361-375. doi: 10.1080/14760584.2017.1256778. Epub 2016 Nov 24. Expert Rev Vaccines. 2017. PMID: 27807989 Review.

5

Economic Costs of Measles Outbreak in the Netherlands, 2013-2014.

Suijkerbuijk AW, Woudenberg T, Hahné SJ, Nic Lochlainn L, de Melker HE, Ruijs WL, Lugnér AK. Suijkerbuijk AW, et al. Among authors: lugner ak. Emerg Infect Dis. 2015 Nov;21(11):2067-9. doi: 10.3201/eid2111.150410. Emerg Infect Dis. 2015. PMID: 26488199 Free PMC article.

6

The burden of Lyme borreliosis expressed in disability-adjusted life years.

van den Wijngaard CC, Hofhuis A, Harms MG, Haagsma JA, Wong A, de Wit GA, Havelaar AH, Lugnér AK, Suijkerbuijk AW, van Pelt W. van den Wijngaard CC, et al. Among authors: lugner ak. Eur J Public Health. 2015 Dec;25(6):1071-8. doi: 10.1093/eurpub/ckv091. Epub 2015 Jun 16. Eur J Public Health. 2015. PMID: 26082446

7

Investment in antiviral drugs: a real options approach.

Attema AE, Lugnér AK, Feenstra TL. Attema AE, et al. Among authors: lugner ak. Health Econ. 2010 Oct;19(10):1240-54. doi: 10.1002/hec.1549. Health Econ. 2010. PMID: 19816857

8

Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men.

Xiridou M, Vriend HJ, Lugner AK, Wallinga J, Fennema JS, Prins JM, Geerlings SE, Rijnders BJ, Prins M, de Vries HJ, Postma MJ, van Veen MG, Schim van der Loeff MF, van der Sande MA. Xiridou M, et al. Among authors: lugner ak. BMC Infect Dis. 2013 Sep 18;13:436. doi: 10.1186/1471-2334-13-436. BMC Infect Dis. 2013. PMID: 24047261 Free PMC article.

9

A Swedish child-friendly pilot version of the EQ-5D instrument--the development process.

Burström K, Egmar AC, Lugnér A, Eriksson M, Svartengren M. Burström K, et al. Among authors: lugner a. Eur J Public Health. 2011 Apr;21(2):171-7. doi: 10.1093/eurpub/ckq037. Epub 2010 Apr 29. Eur J Public Health. 2011. PMID: 20430804

10

[More efficient testing policy at STI clinics].

Suijkerbuijk AW, Over EA, Koedijk FD, van Benthem BH, van der Sande MA, Lugnér AK. Suijkerbuijk AW, et al. Among authors: lugner ak. Ned Tijdschr Geneeskd. 2014;158:A6980. Ned Tijdschr Geneeskd. 2014. PMID: 24642118 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year